Participating in a clinical trial starts with finding a study that matches your health profile, then moving through a structured screening and consent process before enrollment. The entire process from first search to first study visit typically takes a few weeks, though timelines vary by trial. Here’s how each step works.
Find Trials That Match Your Situation
The most comprehensive place to search is ClinicalTrials.gov, a federal database that lists studies across every disease area, treatment type, and location. Start by typing your condition or disease into the search bar, then change the Study Status filter from “All studies” to “Recruiting and not yet recruiting studies” so you only see trials actively looking for participants. You can narrow results further using filters for location, age range, and other eligibility details.
Your doctor is another strong starting point. Specialists often know about trials in their field before they show up in a database search, and they can help you evaluate whether a particular study makes sense given your treatment history. You can also contact research hospitals, advocacy organizations for your condition, or pharmaceutical companies running trials directly. Many trial listings include a phone number or email for the study coordinator, and reaching out to ask questions before committing is standard.
Understand Eligibility Criteria
Every clinical trial has a specific set of requirements that determine who can and cannot join. These exist to protect participants and to make sure the study can produce meaningful results. Common inclusion criteria include age range, a confirmed diagnosis of the condition being studied, disease stage or severity, smoking history, and geographic location. Exclusion criteria might rule out people who have already received certain treatments, who have other medical conditions that could complicate the results, or who are pregnant.
Reading through a trial’s eligibility criteria before you contact the study team saves time. If you’re unsure whether you qualify, reach out anyway. Study coordinators expect these questions and can quickly tell you whether it’s worth pursuing.
The Pre-Screening and Screening Process
Once you’ve identified a trial, the first formal step is a pre-screening meeting. A research nurse or study coordinator will explain the trial’s basics and ask you questions to see if you’re a potential fit. This is usually a phone call or brief in-person visit, not a medical exam.
If pre-screening goes well, a more thorough screening follows. The study team will review your full medical history and run any necessary tests, which might include bloodwork, imaging, or other evaluations depending on the trial. Not everyone who passes pre-screening clears this stage. You may be ruled out based on test results or details in your medical records that weren’t apparent earlier. This is normal and not a reflection of your health overall.
What Informed Consent Actually Covers
Before you’re enrolled, you’ll go through the informed consent process. This is more than signing a form. Federal regulations require the study team to explain eight specific elements to you in language you can understand:
- Purpose and duration: what the study is investigating and how long your participation would last
- Procedures: exactly what will happen during the trial, including which procedures are experimental
- Risks: any foreseeable side effects, discomforts, or dangers
- Benefits: potential advantages to you or to future patients
- Alternatives: other treatment options available to you outside the trial
- Confidentiality: how your personal information will be protected, with a note that the FDA may inspect records
- Compensation for injury: whether medical treatment is available if something goes wrong, and what it includes
- Voluntary participation: a clear statement that you can refuse to join or leave at any time without losing access to your regular care
Take your time with this. You can ask questions, take the consent form home to read, and discuss it with family or your own doctor before signing. Signing does not lock you in.
Know the Trial Phases
Clinical trials happen in phases, and the phase you join affects your experience. Phase 1 trials enroll 20 to 100 people and focus on safety and dosing. These last several months and may include healthy volunteers or people with the condition. Phase 2 trials expand to several hundred participants and test whether the treatment actually works, running several months to two years. Phase 3 trials are the largest, enrolling 300 to 3,000 people over one to four years to confirm effectiveness and monitor for side effects. Phase 4 trials happen after a treatment is already approved and track long-term safety in thousands of participants.
Earlier phases carry more uncertainty because less is known about the treatment. Later phases offer more data on what to expect but may involve longer commitments.
Placebos and Control Groups
Not every trial uses a placebo. In many studies, the comparison group receives the current standard treatment rather than an inactive pill. Whether a trial uses a placebo depends on the condition, the country where it’s conducted, and who funds the study. In one analysis of randomized trials, about 61% used an active treatment as the comparison, while roughly 39% used a placebo. Trials funded by pharmaceutical companies and conducted in the United States are more likely to include placebo groups.
If a trial does use a placebo, the consent form will tell you. You’ll know the probability of being assigned to each group, though in blinded studies you won’t know which group you’re in until the trial ends. For serious conditions where withholding treatment would be dangerous, placebos are generally not used alone. Participants typically receive standard care plus either the experimental treatment or a placebo.
Costs, Compensation, and Insurance
The trial sponsor (usually a pharmaceutical company, university, or government agency) typically covers the cost of the experimental treatment and study-related tests. However, routine medical care you’d receive regardless of the trial, sometimes called “standard of care” costs, may still be billed to your insurance. Coverage varies significantly by insurer and by state, so clarifying this before you enroll is important.
Many trials also pay participants a stipend for their time and inconvenience. The FDA permits this as a recruitment incentive and requires that payment accrue as the study progresses rather than being contingent on completing the entire trial. Travel expenses like parking, airfare, and lodging are often reimbursed separately. Before enrolling, ask the study coordinator specifically which costs you’ll be responsible for and what your insurance will cover.
Your Rights During the Trial
Every clinical trial in the United States is reviewed and approved by an Institutional Review Board, an independent committee that evaluates whether the study is ethically designed and whether the risks to participants are reasonable relative to the potential knowledge gained. The IRB reviews the informed consent process, the inclusion and exclusion criteria, and the overall study plan. It has the authority to suspend or shut down a trial if serious harm occurs or if researchers don’t follow the rules.
Once you’re enrolled, you retain the right to leave the study at any time, for any reason, without penalty. You won’t lose access to any benefits or standard medical care you’re otherwise entitled to. The study team is required to tell you this upfront and to explain what an orderly withdrawal looks like, including any follow-up visits that may be recommended for your safety.
Questions Worth Asking Before You Enroll
Before committing, get clear answers on the practical realities of participation. Ask how often you’ll need to visit the clinic, whether any hospital stays are required, and how far you’ll need to travel. Ask how the trial could affect your daily life and work schedule. Find out what kinds of tests and treatments are involved, how the experimental treatment compares to your current options, and what happens to your care after the trial ends.
On the financial side, ask which costs you’ll pay, which the sponsor covers, and whether anyone on the study team can help navigate questions from your insurance company. On risks, ask what side effects have been observed so far and how they compare to standard treatment. These aren’t confrontational questions. Study teams expect them, and getting straight answers is part of making an informed decision.